Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warde, P.
Right arrow Articles by Payne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warde, P.
Right arrow Articles by Payne, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 10, 890-895, Copyright © 1992 by American Society of Clinical Oncology

ARTICLES

Does thoracic irradiation improve survival and local control in limited- stage small-cell carcinoma of the lung? A meta-analysis

P Warde and D Payne
Department of Radiation Oncology, University of Toronto, Ontario, Canada.

PURPOSE: Our main purpose was to determine whether the addition of thoracic radiation therapy to systemic chemotherapy improves 2-year survival, improves local (intrathoracic) tumor control, and affects treatment-related mortality in patients with limited-stage small-cell carcinoma of the lung. DESIGN: Eleven randomized trials addressing this issue were identified using a computerized literature search (Medline and Cancerline) and by polling senior investigators in the field. A meta-analysis was then performed and the results of the trials were analyzed in two ways, the odds ratio (OR) (Peto) method and the risk difference method (Dersimonian and Laird). RESULTS: The overall OR for benefit of thoracic radiation on 2-year survival (ie, the odds of surviving 2 years among patients allocated to radiation compared with the odds of surviving 2 years among patients allocated to control) is 1.53 (95% confidence interval [CI], 1.30 to 1.76; chi 2 = 12.76; P less than .001). The risk difference method showed that radiation therapy improved 2-year survival by 5.4% (95% CI, 1.1% to 9.7%). Local control results were available for only nine studies, the OR for treatment benefit is 3.02 (95% CI, 2.80 to 3.24; chi 2 = 101.48; P less than .0001), and intrathoracic tumor control was improved by 25.3% (95% CI, 16.5% to 34.1%). The OR for excess treatment-related deaths in the thoracic radiation-treated patients was 2.54 (95% CI, 1.90 to 3.18; chi 2 = 8.24; P less than .01). The risk difference for treatment-related deaths was 1.2% (95% CI, -0.6% to 3.0%). CONCLUSIONS: This meta- analysis shows a small but significant improvement in survival and a major improvement in tumor control in the thorax in patients receiving thoracic radiation therapy. However, this is achieved at the cost of a small increase in treatment-related mortality.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
J. P. Sculier, J. J. Lafitte, A. Efremidis, M. C. Florin, J. Lecomte, M. C. Berchier, M. Richez, T. Berghmans, A. Scherpereel, A. P. Meert, et al.
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
Ann. Onc., October 1, 2008; 19(10): 1691 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
G A Silvestri and S G Spiro
Carcinoma of the bronchus 60 years later
Postgrad. Med. J., April 1, 2008; 84(990): 182 - 187.
[Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
T. Sher, G. K. Dy, and A. A. Adjei
Small Cell Lung Cancer
Mayo Clin. Proc., March 1, 2008; 83(3): 355 - 367.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. T. Shivnani, Y. Fujiwara, K. Hotta, K. Kiura, S. R. Khandelwal, M. Ghaemmaghami, B. Slotman, P. Postmus, and S. Senan
Prophylactic Cranial Irradiation in Small-Cell Lung Cancer
N. Engl. J. Med., November 8, 2007; 357(19): 1977 - 1978.
[Full Text] [PDF]

Home page
 JCOHome page
M. A. Socinski and J. A. Bogart
Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy
J. Clin. Oncol., September 10, 2007; 25(26): 4137 - 4145.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. J. Samson, J. Seidenfeld, G. R. Simon, A. T. Turrisi III, C. Bonnell, K. M. Ziegler, and N. Aronson
Evidence for Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 314S - 323S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. R. Simon and A. Turrisi
Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 324S - 339S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
B. E. Lally, J. J. Urbanic, A. W. Blackstock, A. A. Miller, and M. C. Perry
Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?
Oncologist, September 1, 2007; 12(9): 1096 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. E. Schild, J. A. Bonner, S. Hillman, T. F. Kozelsky, A. P.G. Vigliotti, R. S. Marks, D. L. Graham, G. S. Soori, J. W. Kugler, R. C. Tenglin, et al.
Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)
J. Clin. Oncol., July 20, 2007; 25(21): 3124 - 3129.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Gridelli, C. Langer, P. Maione, A. Rossi, and S. E. Schild
Lung Cancer in the Elderly
J. Clin. Oncol., May 10, 2007; 25(14): 1898 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G A Silvestri and S G Spiro
Carcinoma of the bronchus 60 years later.
Thorax, December 1, 2006; 61(12): 1023 - 1028.
[Full Text] [PDF]

Home page
 JCOHome page
H. Saito, Y. Takada, Y. Ichinose, K. Eguchi, S. Kudoh, K. Matsui, K. Nakagawa, M. Takada, S. Negoro, K. Tamura, et al.
Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902
J. Clin. Oncol., November 20, 2006; 24(33): 5247 - 5252.
[Abstract] [Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
C.-R. Chien and M.-S. Lai
Trends in the Pattern of Care for Lung Cancer and Their Correlation With New Clinical Evidence: Experiences in a University-Affiliated Medical Center
American Journal of Medical Quality, November 1, 2006; 21(6): 408 - 414.
[Abstract] [PDF]

Home page
 Ann OncolHome page
D. De Ruysscher, M. Pijls-Johannesma, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer
Ann. Onc., April 1, 2006; 17(4): 543 - 552.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. De Ruysscher, M. Pijls-Johannesma, S. M. Bentzen, A. Minken, R. Wanders, L. Lutgens, M. Hochstenbag, L. Boersma, B. Wouters, G. Lammering, et al.
Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2006; 24(7): 1057 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Thatcher, W. Qian, P. I. Clark, P. Hopwood, R. J. Sambrook, R. Owens, R. J. Stephens, and D. J. Girling
Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial
J. Clin. Oncol., November 20, 2005; 23(33): 8371 - 8379.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and G. A. Silvestri
One Hundred Years of Lung Cancer
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 523 - 529.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. S. Ettinger, B. A. Berkey, R. A. Abrams, J. Fontanesi, M. Machtay, P. J. Duncan, W. J. Curran Jr, B. Movsas, and R. W. Byhardt
Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study
J. Clin. Oncol., August 1, 2005; 23(22): 4991 - 4998.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Kubota, Y. Nishiwaki, T. Sugiura, K. Noda, K. Mori, M. Kawahara, S. Negoro, K. Watanabe, F. Imamura, T. Tamura, et al.
Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903
Clin. Cancer Res., August 1, 2005; 11(15): 5534 - 5538.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Rossi, P. Maione, G. Colantuoni, C. Guerriero, C. Ferrara, F. Del Gaizo, D. Nicolella, and C. Gridelli
Treatment of Small Cell Lung Cancer in the Elderly
Oncologist, June 1, 2005; 10(6): 399 - 411.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.-Y. Han, K. H. Cho, D. H. Lee, H. Y. Kim, E.-A Kim, S. Y. Lee, and J. S. Lee
Phase II Study of Irinotecan Plus Cisplatin Induction Followed by Concurrent Twice-Daily Thoracic Irradiation With Etoposide Plus Cisplatin Chemotherapy for Limited-Disease Small-Cell Lung Cancer
J. Clin. Oncol., May 20, 2005; 23(15): 3488 - 3494.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. B. Fried, D. E. Morris, C. Poole, J. G. Rosenman, J. S. Halle, F. C. Detterbeck, T. A. Hensing, and M. A. Socinski
Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer
J. Clin. Oncol., December 1, 2004; 22(23): 4837 - 4845.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q.-T. Le, J. McCoy, S. Williamson, J. Ryu, L. E. Gaspar, M. J. Edelman, S. R. Dakhil, S. D. Sides, J. J. Crowley, and D. R. Gandara
Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): A Southwest Oncology Group Study
Clin. Cancer Res., August 15, 2004; 10(16): 5418 - 5424.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Brenner, L. H. Tang, D. S. Klimstra, and D. P. Kelsen
Small-Cell Carcinomas of the Gastrointestinal Tract: A Review
J. Clin. Oncol., July 1, 2004; 22(13): 2730 - 2739.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S.-H. Lee, Y. C. Ahn, H. J. Kim, D. H. Lim, S. I. Lee, E. Nam, S. H. Park, J. Park, K.-E. Lee, J. O. Park, et al.
Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer
Jpn. J. Clin. Oncol., December 1, 2003; 33(12): 620 - 625.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. M. Kamel, D. Zwahlen, M. T. Wyss, K. D. Stumpe, G. K. von Schulthess, and H. C. Steinert
Whole-Body 18F-FDG PET Improves the Management of Patients with Small Cell Lung Cancer
J. Nucl. Med., December 1, 2003; 44(12): 1911 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Reck, J. von Pawel, H.-N. Macha, E. Kaukel, K.-M. Deppermann, R. Bonnet, K. Ulm, S. Hessler, and U. Gatzemeier
Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer
J Natl Cancer Inst, August 6, 2003; 95(15): 1118 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Booton, M Jones, and N Thatcher
Lung cancer * 7: Management of lung cancer in elderly patients
Thorax, August 1, 2003; 58(8): 711 - 720.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Lu, R. Komaki, J. S. Lee, D. M. Shin, J. L. Palmer, B. J. Coldman, K. M. Pisters, J. M. Kurie, F. V. Fossella, and B. S. Glisson
A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer
Clin. Cancer Res., June 1, 2003; 9(6): 2085 - 2091.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. R. Simon and H. Wagner
Small Cell Lung Cancer
Chest, January 1, 2003; 123(1_suppl): 259S - 271S.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Sundstrom, R. M. Bremnes, S. Kaasa, U. Aasebo, R. Hatlevoll, R. Dahle, N. Boye, M. Wang, T. Vigander, J. Vilsvik, et al.
Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years' Follow-Up
J. Clin. Oncol., December 15, 2002; 20(24): 4665 - 4672.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. Osterlind
Chemotherapy in small cell lung cancer
Eur. Respir. J., December 1, 2001; 18(6): 1026 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. M. Bremnes, S. Sundstrom, J. Vilsvik, and U. Aasebo
Multicenter Phase II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Cancer
J. Clin. Oncol., August 1, 2001; 19(15): 3532 - 3538.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Glisson, C. Scott, R. Komaki, B. Movsas, and H. Wagner
Cisplatin, Ifosfamide, Oral Etoposide, and Concurrent Accelerated Hyperfractionated Thoracic Radiation for Patients With Limited Small-Cell Lung Carcinoma: Results of Radiation Therapy Oncology Group Trial 93-12
J. Clin. Oncol., August 16, 2000; 18(16): 2990 - 2995.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hugli, D. Moro, B. Mermillod, M. Bolla, P. Alberto, H. Bonnefoi, and R. Miralbell
Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer
J. Clin. Oncol., April 1, 2000; 18(8): 1662 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Levitan, A. Dowlati, D. Shina, M. Craffey, W. Mackay, R. DeVore, J. Jett, S. C. Remick, A. Chang, and D. Johnson
Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma
J. Clin. Oncol., March 1, 2000; 18(5): 1102 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Elias
Hematopoietic Stem Cell Transplantation for Small Cell Lung Cancer*
Chest, December 1, 1999; 116(suppl_3): 531S - 538S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. B. Marks and G. Sibley
The Rationale and Use of Three-Dimensional Radiation Treatment Planning for Lung Cancer*
Chest, December 1, 1999; 116(suppl_3): 539S - 545S.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. N. Carney
Prophylactic Cranial Irradiation and Small-Cell Lung Cancer
N. Engl. J. Med., August 12, 1999; 341(7): 524 - 526.
[Full Text]

Home page
 JCOHome page
A. Elias, J. Ibrahim, A. T. Skarin, C. Wheeler, M. McCauley, L. Ayash, P. Richardson, L. Schnipper, K. H. Antman, and E. Frei III
Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome
J. Clin. Oncol., April 1, 1999; 17(4): 1175 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. S. Lichter and T. S. Lawrence
Recent Advances in Radiation Oncology
N. Engl. J. Med., February 9, 1995; 332(6): 371 - 379.
[Full Text] [PDF]

Home page
 NEJMHome page
J. Lau, J. Berlin, T. C. Chalmers, J.-P. Pignon, and R. Arriagada
Meta-Analysis of Radiotherapy for Small-Cell Lung Cancer
N. Engl. J. Med., May 13, 1993; 328(19): 1425 - 1426.
[Full Text]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1992 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online